Actinium Pharmaceuticals Inc (AMEX:ATNM)’s 12-Month Price Target Currently Stands At 24.26
In last trading session, Actinium Pharmaceuticals Inc (AMEX:ATNM) saw 0.38 million shares changing hands with its beta currently measuring -0.27. Company’s recent per share price